OptiNose Competitors and Similar CompaniesClear all
OptiNose's competitors and similar companies include Veloxis Pharmaceuticals, Intersect ENT, Avedro and DCC Vital.
 Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. |  Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. |  Avedro Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals. | |||
Founding Date | Founding Date 2000 | Founding Date 2002 | Founding Date 2003 | Founding Date 2002 | Founding Date 1829 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Morrisville, US HQ Oslo, NO Swindon, GB | Locations København, DK HQ Cary, US Cary, US | Locations Menlo Park, US HQ | Locations Waltham, US HQ | Locations Dublin 18, IE HQ |
Employees | Employees 2048% decrease | Employees 54 | Employees 4337% increase | Employees 122 | Employees 5681% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) $78.2m (FY, 2024) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $27.7m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods $7.2m (FY, 2024) | Cost of goods kr7.9m (FY, 2018) | Cost of goods $30m (FY, 2021) | Cost of goods $10.9m (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit $71m (FY, 2024) | Gross profit kr31.6m (FY, 2018) | Gross profit $76.7m (FY, 2021) | Gross profit $16.8m (FY, 2018) | Gross profit N/A |
Net income | Net income ($21.5m) (FY, 2024) | Net income (kr5.3m) (FY, 2018) | Net income ($159.6m) (FY, 2021) | Net income ($25.1m) (FY, 2018) | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) 43 (Jun, 2017) | Patents (US) N/A | Patents (US) 30 (FY, 2016) | Patents (US) 15 (Mar, 2019) | Patents (US) N/A |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 77 (FY, 2016) | Patents Issued 42 (Mar, 2019) | Patents Issued N/A |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks 29 (FY, 2016) | Trademarks 56 (Mar, 2019) | Trademarks N/A |
Trademarks (US) | Trademarks (US) 3 (Jun, 2017) | Trademarks (US) N/A | Trademarks (US) 4 (FY, 2016) | Trademarks (US) 10 (Mar, 2019) | Trademarks (US) N/A |
Trademarks Pending | Trademarks Pending N/A | Trademarks Pending N/A | Trademarks Pending 35 (FY, 2016) | Trademarks Pending 19 (Mar, 2019) | Trademarks Pending N/A |
Funding | |||||
Total funding raised | Total funding raised $ 120.5m | Total funding raised $ 60m | Total funding raised $ 102.9m | Total funding raised $ 67.6m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View companyIntersect ENT
HQ
Menlo Park, US
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
View companyAvedro
HQ
Waltham, US
Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals.
View company
DCC Vital
HQ
Dublin 18, IE
DCC Vital is a company that provides pharmaceuticals and medical devices.
View company